Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00500513 · ClinicalTrials.gov registry record · NA

Tracking of Respiratory-Induced Tumor Motion Using Implanted Fiducials

A NA study of Lung Cancer, sponsored by M.D. Anderson Cancer Center.

Completed
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT00500513: Completed NA study of Lung Cancer, sponsored by M.D. Anderson Cancer Center.

NCT00500513 is a NA study of Lung Cancer that has completed, run by M.D. Anderson Cancer Center. The registered enrollment target is 10 participants, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist → Add completion date to calendar (.ics) →

The verdict

NCT00500513, a NA study of Lung Cancer, has completed, sponsored by M.D. Anderson Cancer Center.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

Objectives: * To determine the safety of fiducial implantation. * To determine the extent/rate of migration of radio-opaque fiducials placed in lung tumors and adjacent normal tissue. * To compare real-time portal imaging-based fiducial tracking with measurement of three-dimensional motion by four-dimensional CT scanning to determine how many fiducials are needed to track a tumor. * To determine if intra-fractional lung tumor motion changes during a course of treatment, and when during the treatment this occurs. * To correlate the position of internal fiducials with the position of the external patient surface during respiration. * To quantify the residual motion of the clinical target volume during radiotherapy gated using external fiducials. * To verify the adequacy of the treatment portal margins in encompassing the residual motion of the clinical target volume. * To determine if radio-opaque fiducial placement adjacent to the trachea (which does not move) can reduce daily setup inaccuracies, and so spare normal tissue. * To determine the motion of hilar adenopathy (if any), and whether it correlates with motion of the primary tumor.

Conditions Studied

Interventions

  • PROCEDURE CT Scans
  • PROCEDURE Implanted markers
  • RADIATION Radiation Treatment (RT)

Study Locations (1)

Texas

  • UT MD Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2004-04
Est. Completion 2011-12
Phase NA
M.D. Anderson Cancer Center

2,692 total trials

What the finished NCT00500513 record still lists

NCT00500513 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 10 participants, a relatively small participant target, below the 936-participant average among 409 other Lung Cancer trials with a reported enrollment target (99% lower).

The record links to 1 condition, with Lung Cancer appearing as the primary indexed condition, and to 3 interventions - of which CT Scans is the first listed.

NCT00500513 reports a single indexed study location in Texas.

Frequently Asked Questions

What is clinical trial NCT00500513 about?

NCT00500513 is a clinical study titled "Tracking of Respiratory-Induced Tumor Motion Using Implanted Fiducials". Objectives: * To determine the safety of fiducial implantation. * To determine the extent/rate of migration of radio-opaque fiducials placed in lung tumors and adjacent normal tissue. * To compare real-time portal imaging-based fiducial tracking with measurement of three-dimensional motion by four-...

What is the current status of trial NCT00500513?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2004-04. Estimated completion is 2011-12.

What conditions does trial NCT00500513 study?

This clinical trial studies the following conditions: Lung Cancer.

What interventions are being tested in trial NCT00500513?

The interventions under investigation include: CT Scans (PROCEDURE), Implanted markers (PROCEDURE), Radiation Treatment (RT) (RADIATION).

Who is sponsoring clinical trial NCT00500513?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00500513 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Lung Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00500513's enrollment target sits among peer trials

10 393rd of 409 higher than 14 of 409 other Lung Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Lung Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00623389 · 10 participants · NA

    Evaluation of an Advanced Lower Extremity Neuroprostheses

  • NCT01241864 · 10 participants · Phase 2

    Islet Transplantation in Type 1 Diabetic Kidney Allograft

  • NCT01293214 · 10 participants · NA

    Vascularized Composite Allotransplantation for Multiple Extremity Amputations

  • NCT01474148 · 10 participants · NA

    A Neuroprosthesis for Seated Posture and Balance

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00500513, the US trial registry maintained by the National Library of Medicine. NCT00500513 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.